Related by context. All words. (Click for frequent words.) 75 hepatitis B HBV 70 chronic HCV infection 70 thymosin alpha 1 70 systemic fungal infections 69 herpes zoster shingles 69 sorafenib tablets 69 cytomegalovirus CMV 69 Daclizumab 69 cat dander allergy 69 dasatinib Sprycel ® 69 Zolinza 68 zidovudine AZT 68 refractory chronic lymphocytic 68 CCR5 tropic HIV 68 RhuDex ® 68 latent tuberculosis infection 68 Hepatitis C HCV 68 recurrent glioblastoma multiforme 68 post herpetic neuralgia PHN 68 CYT# potent vascular disrupting 68 Kit CD# positive 68 Chronic lymphocytic leukemia 68 oropharyngeal candidiasis OPC 68 chronic HBV infection 68 chronic HCV 68 candidemia 68 relapsed MM 67 MKC# MT 67 refractory gout 67 hepatitis C genotype 67 cIAI 67 GW# [003] 67 treatment naïve genotype 67 HCV genotypes 67 relapsing remitting MS RRMS 67 chronic hepatitis C 67 relapsed leukemia 67 AEG# 67 e antigen HBeAg 67 cutaneous T 67 Xyfid TM 67 Alinia 67 dasatinib Sprycel 67 forodesine 67 erlotinib Tarceva ® 67 investigational monoclonal antibody 67 protease inhibitor PI 67 histone deacetylase HDAC inhibitor 67 Diabetic Macular Edema 67 CTAP# Capsules 67 Alferon LDO 67 Vitrasert R 67 Recombinant interferon alpha 67 antibody MAb 67 YONDELIS 67 metastatic neuroendocrine tumors 67 HCV infections 67 acyclovir Lauriad R 67 leukemia AML 67 LymphoStat B belimumab 66 hepatitis C virus HCV 66 Viread tenofovir disoproxil fumarate 66 diarrhea predominant irritable 66 methylnaltrexone bromide 66 Evoltra ® 66 Hepatitis C virus HCV 66 CIMZIA TM certolizumab pegol 66 ZADAXIN ® 66 nucleotide analogue 66 Velcade bortezomib 66 Aflibercept 66 HCV genotype 1 66 imatinib Gleevec ® 66 virus HCV infection 66 FOLOTYN ® 66 symptomatic BPH 66 HBeAg negative 66 IV Busulfex 66 VitiGam 66 MAGE A3 ASCI 66 tigecycline 66 recurrent NSCLC 66 nucleotide analog 66 Valopicitabine 66 Epratuzumab 66 Albuferon TM 66 invasive candidiasis 66 Nitazoxanide 66 treatment naive genotype 66 phase III isavuconazole 66 relapsed multiple myeloma 66 Lymphocytic 66 Ozarelix 66 decompensated liver disease 66 ceftazidime 66 CCR5 tropic 66 ketolide antibiotic 66 alfa 2a 66 hypereosinophilic syndrome 66 Clevudine 66 SPRYCEL ® 66 IMA# 66 Alemtuzumab 65 OncoVEX GM CSF 65 toenail onychomycosis 65 novel VDA molecule 65 Myelodysplastic syndromes MDS 65 chronic opioid 65 non nucleoside inhibitor 65 OncoVex 65 virus HCV 65 chemotherapy induced neutropenia 65 Diabetic Macular Edema DME 65 cutaneous T cell 65 chronic hepatitis C. 65 oral proteasome inhibitor 65 Solazed TM 65 ALN TTR 65 OHR/AVR# 65 advanced metastatic renal 65 interferon gamma 1b 65 HuMax CD4 65 NS5b 65 Human papilloma virus 65 BARACLUDE ® 65 HCV infection 65 Sustiva efavirenz 65 protease inhibitors PIs 65 recurrent glioma 65 phase IIb clinical 65 castrate resistant prostate cancer 65 cytomegalovirus infection 65 kidney urologic 65 oncolytic virus therapies 65 Amgen Neulasta R 65 pegylated interferon alfa 2a 65 non metastatic osteosarcoma 65 recurrent genital herpes 65 Thiovir 65 Respiratory syncytial virus RSV 65 prokinetic agent 65 Hepatitis C Virus HCV 65 AmBisome 65 LymphoStat B TM 65 Dalbavancin 65 HepaGam B TM 65 synthetic retinoid 65 PNP inhibitor 65 elotuzumab 65 LHRH antagonists 65 non alcoholic steatohepatitis 65 AA Amyloidosis 65 combination antiretroviral therapy 65 cardio renal 65 nosocomial pneumonia 65 CMV infection 65 varicella zoster virus VZV 65 Hepatocellular Carcinoma HCC 65 MVA BN R 65 BCR ABL inhibitor 65 vWD 65 Fludara ® 65 cirrhosis liver failure 65 Temsirolimus 65 efalizumab 65 gastrointestinal stromal tumors GIST 65 TYZEKA 65 Phase #b/#a clinical 65 NS#/#A protease 65 Gleevec resistant 65 CCR5 antagonist 65 mapatumumab 65 Blinatumomab 65 methicillin resistant S. aureus 65 Acute myeloid leukemia 65 lenalidomide Revlimid R 65 Gleevec imatinib mesylate 65 chronic HCV genotype 65 essential thrombocythemia ET 65 Genentech Rituxan 65 evaluating tivozanib 65 Vandetanib 65 mertansine 64 Degarelix 64 Rilonacept 64 HCV NS5B polymerase 64 R sorafenib tablets 64 chronic HBV 64 micafungin 64 myelodysplastic myeloproliferative diseases 64 lymphoma CTCL 64 ORENCIA ® 64 LEUKINE 64 chronic hepatitis B. 64 eosinophilic asthma 64 cryptococcosis 64 Cimzia TM 64 invasive fungal infections 64 RhuDex R 64 MGd 64 Tofacitinib 64 bendamustine HCl 64 Eraxis 64 KETEK 64 investigational integrase inhibitor 64 HQK 64 pegylated interferon alpha 64 Vicriviroc 64 Cetrorelix 64 INVANZ 64 Tyzeka 64 Ecallantide 64 AA amyloidosis 64 relapsed refractory multiple myeloma 64 hepatitis B virus HBV 64 oral RSD# 64 mRCC 64 polymerase inhibitor 64 biologic DMARD 64 Tipranavir 64 neuroendocrine cancers 64 relapsing multiple sclerosis 64 Naive Patients 64 Immunotherapeutic 64 oropharyngeal candidiasis 64 RELOVAIR ™ 64 Chronic hepatitis B 64 gastrointestinal disorders ATI 64 CMV retinitis 64 HIV1 64 CMV disease 64 Leukemias 64 posterior uveitis 64 DEB# 64 idiopathic pulmonary fibrosis IPF 64 Neisseria gonorrhoeae 64 Insegia 64 proteasome inhibitor 64 ano genital warts 64 Neulasta ® 64 Opportunistic infections 64 de novo kidney transplant 64 Pegasys ® 64 CCR5 receptor antagonist 64 Epstein Barr virus EBV 64 SinuNase TM 64 Hepatitis B Hepatitis C 64 reslizumab 64 TMC# C# 64 SNT MC# 64 commercialize deforolimus 64 ROTATEQ 64 Vicinium TM 64 Quinamed 64 nucleoside analogue 64 C1 esterase inhibitor 64 HepC 64 leukemia ALL 64 refractory chronic myeloid 64 TREANDA 64 Nexavar ® 64 Actimmune ® 64 ALN PCS 64 tumors GIST 64 smoldering myeloma 64 Traficet EN 64 metastatic renal cell 64 PEGylated Fab fragment 64 oral nucleoside analogue 64 leukemia CLL 64 chronic myeloid 64 immunocompromised patients 64 Annamycin 64 Vaccine Recombinant 64 MDR tuberculosis 64 Amrubicin 64 OZURDEX ® 64 formerly LymphoStat B 64 lupus nephritis 64 Veronate 64 Vitrasert ® 64 drug ISA# 64 docetaxel Taxotere ® 64 Lubiprostone 64 NS5B polymerase 64 oral ridaforolimus 64 ACTEMRA TM 64 myelofibrosis polycythemia vera 64 Shigamabs ® 64 immunomodulator 64 Virulizin ® 64 lintuzumab SGN 64 Canvaxin TM 64 oral deforolimus 64 vaginal candidiasis 64 hematological malignancy 64 adult chronic ITP 64 Elacytarabine 64 basal cell carcinoma BCC 64 EOquin TM 64 lumiliximab 64 nucleoside analogues 64 androgen receptor antagonist 64 biodefense pathogens 64 Apaziquone 64 constipation OIC 64 Pemetrexed 64 chronic ITP patients 64 DEFLUX 64 Cloretazine 63 Irinotecan 63 TTR amyloidosis 63 Cethromycin 63 sorafenib Nexavar 63 oral prodrug 63 nucleoside analog 63 multiple myeloma MM 63 PREZISTA r 63 pan HDAC inhibitor 63 Human papillomavirus HPV 63 Azedra 63 Chronic HCV infection 63 dirucotide MBP# 63 GVAX ® 63 Arcalyst 63 Moxifloxacin 63 minimally symptomatic metastatic castrate 63 Chronic Myelogenous Leukemia CML 63 CEQ# 63 NXL# 63 Reverset 63 trabectedin 63 Bezielle 63 rilonacept 63 VIR# 63 ara C 63 HIV coinfected 63 BCG refractory carcinoma 63 Edurant 63 peritumoral brain edema 63 noninfectious uveitis 63 Ceflatonin R 63 Natalizumab 63 TYGACIL 63 adalimumab Humira 63 Nexavar sorafenib 63 virus HCV protease inhibitor 63 receptor tyrosine kinase inhibitor 63 Etravirine 63 Actemra tocilizumab 63 Personalized Immunotherapy 63 transcriptase inhibitor NNRTI 63 SUPPRELIN R LA 63 CERVARIX 63 Allovectin 7 ® 63 CD3 monoclonal antibody 63 herpetic keratitis 63 Interferon beta 63 Epidermal Growth Factor Receptor 63 arthritis PsA 63 diabetic neuropathic pain 63 hematologic disorders 63 advanced hepatocellular carcinoma 63 basiliximab 63 Ofatumumab 63 oral dual endothelin 63 Omacetaxine 63 Aviptadil 63 thalidomide Thalomid 63 riociguat 63 pediatric acute lymphoblastic 63 Vidaza R 63 immunomodulatory therapy 63 Renal Cell Carcinoma RCC 63 equine osteoarthritis 63 posaconazole 63 PEGylated anti 63 grade cervical intraepithelial 63 systemic juvenile idiopathic 63 chronic eosinophilic leukemia 63 carcinoid syndrome 63 opioid induced constipation OIC 63 metastatic malignant melanoma 63 Trichomonas vaginalis 63 MyVax R 63 Sebivo 63 Silodosin 63 Cleviprex TM clevidipine 63 Peginterferon alfa 2b 63 sJIA 63 sodium stibogluconate 63 SHPT 63 oral herpes 63 Complicated Skin 63 debilitating autoimmune 63 Hereditary angioedema HAE 63 ChronVac C R 63 indinavir Crixivan 63 latent tuberculosis TB 63 Voreloxin 63 Aptivus ® 63 recombinant hepatitis B 63 haematologic malignancies 63 radiation sensitizer 63 metastatic renal cell carcinoma 63 HCD# [002] 63 generation purine nucleoside 63 cSSSIs 63 CDAD Clostridium difficile 63 DermaVir Patch 63 Tesetaxel 63 PREVNAR 63 calcineurin inhibitors 63 autoantibody positive 63 disease CDAD 63 Tamibarotene 63 terlipressin 63 Crohn disease CD 63 BARACLUDE R 63 HIV integrase inhibitors 63 small molecule thrombopoietin 63 Copegus ribavirin 63 omega interferon 63 Pirfenidone 63 Ribavirin causes 63 nonsmall cell lung cancer 63 bortezomib Velcade R 63 Pegylated Interferon 63 lucinactant 63 rheumatoid arthritis psoriatic arthritis 63 Belimumab 63 miconazole Lauriad ® 63 ROTARIX 63 antibiotic resistant bacterial infections 63 viral subtypes 63 Tarvacin 63 Cervista HPV HR 63 cancer mCRC 63 naive HCV genotype 63 NRTI resistance 63 Wafer polifeprosan 63 cetuximab Erbitux R 63 Genasense ® 63 Chlamydia trachomatis 63 signal transduction inhibitors 63 ELACYT 63 Phase III Pivotal 63 multidrug resistant TB MDR 63 HCV SPRINT 63 AVONEX ® 63 null responder 63 meropenem 63 infliximab Remicade 63 stage IIIB 63 HCV genotype 63 Elotuzumab 63 Lenocta 63 Cx# [002] 63 calcineurin inhibitor 63 Dacogen decitabine 63 JAK inhibitor 63 vidofludimus 63 Certolizumab pegol 63 BAY #-# 63 visilizumab 63 Onalta 63 Lupus nephritis 63 refractory cutaneous T 63 targeted radiotherapeutic 63 SCIg 63 thetreatment 63 Dapagliflozin 63 advanced metastatic prostate 63 Chronic Hepatitis B 63 STELARA TM 63 Clostridium difficile associated 63 BCR ABL inhibitors 63 budesonide foam 63 pelvic malignancies 63 Elvitegravir 63 Dementia Related Psychosis 63 TBC# 63 discontinued Viread 63 Chronic hepatitis C 63 genital herpes infections 63 selective modulator 63 vapreotide acetate 63 including eniluracil ADH 63 APTIVUS 63 Allovectin 7 R 63 ORENCIA R 63 Archexin 63 Genital herpes 63 Fibrillex TM 63 tenofovir emtricitabine 63 IMiDs ® compound 63 Intravenous CP 63 Fc fusion protein 63 Pulmonary Arterial Hypertension PAH 63 Atripla combines 63 humanized monoclonal antibody 63 overactive bladder syndrome 63 APTIVUS r 63 solithromycin 63 genotype 1b 63 Hodgkin lymphoma HL 63 thymalfasin 63 Elagolix 63 FS Antihemophilic Factor Recombinant 62 cell lymphoma CTCL 62 oral candidiasis 62 Bendamustine 62 VivaGel TM 62 liver transplantations 62 Atypical Hemolytic Uremic Syndrome 62 CTAP# 62 ZACTIMA 62 superficial bladder cancer 62 canakinumab 62 sodium thiosulfate STS 62 null responder HCV 62 Heterozygous Familial Hypercholesterolemia 62 Waldenstrom macroglobulinemia 62 targeting CD# 62 serotype #A 62 IMC #B 62 Dacetuzumab 62 cystic fibrosis bronchiectasis 62 cytomegalovirus CMV retinitis 62 CD# monoclonal antibody 62 LTBI 62 Certican 62 oncological indications 62 Oral NKTR 62 HCV polymerase inhibitors 62 chronic lymphocytic leukemia CLL 62 IMiDs 62 Tigecycline 62 R5 tropic 62 BENLYSTA TM 62 STELARA ™ 62 Maribavir 62 VZV 62 Allovectin 7 62 PEG interferon 62 candidate XP# 62 SJIA 62 Interferon alpha 62 RhuDex TM 62 metastatic castrate resistant 62 PD LID 62 Proleukin 62 oral ghrelin agonist 62 OvaRex ® MAb 62 metastatic bladder 62 allogeneic HSCT 62 Glufosfamide 62 chlamydial infections 62 virus HBV 62 MYDICAR ® 62 Systemic lupus erythematosus SLE 62 investigational protease inhibitor 62 demonstrated antitumor activity 62 hyperplasia BPH 62 MabThera Rituxan 62 alvespimycin 62 AVASTIN 62 Zorbtive TM 62 Myelodysplastic syndromes 62 leukemia APL 62 Phase Ib clinical 62 EndoTAG TM -1 62 phase IIb study 62 Levofloxacin 62 oncogenic HPV 62 idiopathic thrombocytopenic purpura ITP 62 Mycamine 62 sunitinib Sutent ® 62 brand ciclesonide HFA 62 Campath ® 62 diarrhea CDAD 62 Taiho Pharmaceutical 62 vaccine LAIV 62 esophageal candidiasis 62 Teplizumab 62 First Patient Dosed 62 Noxafil 62 Kepivance 62 cidofovir 62 benign prostatic hypertrophy BPH 62 Tasigna nilotinib 62 Factor VIIa 62 Xanafide 62 humanized anti 62 HBV vaccine 62 GARDASIL ® 62 sitaxsentan 62 Prodarsan R 62 Kivexa 62 HER2 overexpression 62 Twinrix 62 refractory multiple myeloma 62 multi kinase inhibitor 62 Sudhir Agrawal D.Phil 62 Pafuramidine 62 generation NNRTI 62 pomalidomide 62 IMiDs ® 62 hepatocellular cancer 62 Valcyte 62 HER2 positive metastatic breast 62 resistant hormone refractory 62 TransVax ™ 62 anti CD3 monoclonal 62 R rilonacept Injection 62 HGS ETR1 mapatumumab 62 LHRH receptor positive 62 Dacogen injection 62 metastatic colorectal 62 Septin9 62 Tibotec Therapeutics division 62 alemtuzumab Campath 62 HPV-#/# 62 mGluR5 NAM 62 Telintra 62 G#DT 62 inhibitor RG# 62 Telbivudine 62 Copegus R 62 SNT-MC#/idebenone 62 either acutely decompensated 62 rALLy clinical trial 62 Hedgehog Pathway Inhibitor 62 CCR5 mAb 62 Gilead Viread 62 huN# DM1 62 TRANSDUR ™ 62 PEGylated interferon beta 1a 62 Synflorix 62 Navelbine ® 62 Human papillomavirus 62 Methylnaltrexone 62 Pradefovir 62 efavirenz emtricitabine 62 systemic lupus erythematosus SLE 62 KRN# 62 investigational oral inhibitor 62 Pegylated interferon 62 baminercept 62 human African trypanosomiasis 62 GRNVAC1 62 systemic RNAi therapeutic 62 Severe Sepsis 62 sapropterin dihydrochloride Tablets 62 K ras mutations 62 Virulizin R 62 containing granisetron 62 Systemic lupus erythematosus 62 inflammatory demyelinating 62 Bucindolol 62 candidate CRLX# 62 alpha interferons 62 PREVENAR 62 Neulasta R 62 Cerebril TM 62 chlamydial infection 62 ribavirin Copegus ® 62 relapsed ovarian cancer 62 immunosuppressed patients 62 hypercholesterolemic patients 62 ZOSTAVAX 62 methylnaltrexone 62 Paromomycin 62 ofatumumab HuMax CD# 62 immunological diseases 62 huC# DM4 62 metastatic malignant 62 Raptiva ® 62 Myocet 62 Cytomegalovirus CMV 62 Shigatoxin producing E. coli 62 Staphylococcus aureus infections 62 Severe Primary IGFD 62 personalized cellular immunotherapy 62 treat lupus renal 62 Stanate R 62 Aurexis 62 Golimumab 62 orthopoxvirus 62 Advanced Renal Cell 62 Candida infection 62 minimally symptomatic 62 hyperphenylalaninemia HPA due 62 agonistic human 62 Raptiva R 62 Ranibizumab 62 Fabry Disease 62 immunotherapeutic vaccine 62 Herceptin trastuzumab 62 IV acetaminophen 62 HIV integrase inhibitor 62 DDP# 62 MT#/MEDI-# 62 grade cervical dysplasia 62 phase IIb trial 62 aripiprazole Abilify 62 cytokine Interleukin 62 Leukine ® 62 neovascular diseases 62 R roscovitine 62 Sapacitabine 62 Ganciclovir 62 alkylating agent 62 delta opioid receptor 62 Tarceva TM 62 VISICOL R 62 selective immunoproteasome inhibitor 62 COPEGUS R 62 HuLuc# 62 virus XMRV 62 oral Janus kinase 62 intravesical instillation 62 MPS IVA 62 gefitinib Iressa 62 ZYVOX 62 hepatocellular carcinoma HCC 62 REYATAZ ® 62 Provectus Pharmaceuticals specializes 62 Romiplostim 62 induced macular edema 62 investigational compounds 62 peginterferon alfa 2a Pegasys 62 TransVax TM 62 essential thrombocythemia 62 Peg IFN 62 Ceftaroline 62 radezolid 62 humanized monoclonal 62 PrevOnco 62 multicenter Phase III 62 MKC# MKC# PP 62 gastro intestinal inflammation 62 NOMID 62 TLR9 agonist 62 SIMPONI TM 62 Relapsed Refractory 62 metastatic gastric 62 HCV protease inhibitor 62 DU #b 62 catheter occlusion 62 organ transplant rejection 62 temsirolimus Torisel 62 CMV reactivation 62 gastrointestinal stromal tumors 62 oral vancomycin 62 regorafenib 62 Entecavir 62 sodium glucose cotransporter 62 panobinostat 62 BiTE R 62 simplex virus 62 daptomycin 62 rilpivirine 62 abacavir Ziagen 62 evaluating REVLIMID 62 Bronchiectasis 62 ZALBIN 62 include Alferon N 62 Dasatinib 62 PROSTVAC TM 62 Systemic Sclerosis 62 invasive aspergillosis 62 Onalta TM 62 acyclovir Lauriad ® 62 delayed onset CINV 62 Uvidem 62 AGILECT R 62 Myelodysplastic Syndrome MDS 62 HCV infected 62 antibody MT# 61 SYN# 61 Arranon 61 Monoclonal antibody 61 protein tyrosine phosphatase 1B 61 cinacalcet HCl 61 taxane chemotherapy 61 beta interferons 61 Rheumatoid Arthritis RA 61 Combination REOLYSIN R 61 delayed CINV 61 ATG Fresenius S 61 Copegus ® 61 BR.# 61 cetuximab Erbitux ® 61 postoperative ileus 61 investigational therapies 61 R Saizen R 61 vinca alkaloid 61 registrational trial 61 secondary hyperparathyroidism 61 acute GvHD 61 BCG refractory 61 chimeric monoclonal antibody 61 TELCYTA 61 Proxinium TM 61 Pharmacokinetics PK 61 overactive bladder OAB 61 TELINTRA 61 humanized monoclonal antibodies 61 Lipsovir ® 61 ARCALYST 61 Tezampanel 61 Idiopathic Pulmonary Fibrosis 61 SEBIVO 61 B CLL 61 Pyridorin 61 rasagiline tablets 61 CINTREDEKIN BESUDOTOX 61 Nimotuzumab 61 Gemzar ® 61 recombinant adeno associated 61 Laquinimod 61 non nucleoside HCV 61 diabetic kidney 61 lexidronam injection 61 external genital lesions 61 chronic myeloid leukemia CML 61 Prodarsan ® 61 nucleoside naive 61 metastatic hormone refractory 61 R#/MEM 61 INSPIRE Trial Phase III 61 Hepatitis B Virus 61 trastuzumab DM1 T DM1 61 Aplidin R 61 FUSILEV ® 61 ribavirin Copegus 61 Homspera TM 61 histone deacetylase inhibitor 61 IL# PE#QQR 61 refractory AML 61 OMP #M# 61 pegylated interferon alfa 61 Treatment Experienced 61 Liprotamase 61 cilengitide 61 ALN HPN 61 glioblastoma multiforme GBM 61 Onalta ™ 61 shingles herpes zoster 61 C. trachomatis 61 R bendamustine hydrochloride 61 P#X# antagonist 61 Clofarabine 61 stage IIIb IV 61 VivaGel ™ 61 Zalypsis 61 Cutaneous T 61 hepatitis C virus 61 chickenpox varicella 61 Alferon N 61 somatostatin analogue 61 Escherichia coli Klebsiella pneumoniae 61 AzaSite TM 61 neuraminidase inhibitor 61 TORISEL 61 complement inhibitor eculizumab 61 Hsp# Inhibitor 61 HCV 61 herpes zoster virus 61 Clolar ® 61 metastatic GIST 61 MEK Inhibitor 61 labial herpes 61 romidepsin 61 AGHD 61 AZT zidovudine Retrovir 61 MALT lymphoma 61 Philadelphia Chromosome Positive 61 ribavirin RBV 61 Phase #/#a trial 61 corticosteroid dexamethasone 61 Remicade infliximab 61 Testosterone MDTS R 61 vitreoretinal disorders 61 Talabostat 61 trastuzumab Herceptin R 61 parasite Trypanosoma cruzi 61 Vidaza azacitidine 61 OMP #R# 61 antisense drug 61 MYLOTARG 61 Aliskiren 61 Xyrem ® 61 Major Depressive Disorder MDD 61 orally administered inhibitor 61 Chronic myeloid leukemia 61 JAK2 inhibitor 61 selective androgen receptor modulator 61 Diamyd ® 61 metaglidasen 61 alefacept 61 PGL# 61 INS# [001] 61 Filgrastim 61 modified glutathione analog 61 post transplant lymphoproliferative 61 infections cIAI 61 ADPKD 61 Respiratory Syncytial Virus RSV 61 pegylated liposomal doxorubicin 61 pegylated interferons 61 bacterial respiratory infections 61 Bacille Calmette Guérin BCG 61 immune modulators 61 orally inhaled migraine 61 chronic Hepatitis B 61 microtubule inhibitor 61 Didanosine 61 bacterium Neisseria meningitidis 61 Relapsing remitting MS 61 herpes simplex viruses 61 inhibit replication 61 paromomycin 61 ergot derivatives 61 Bavituximab 61 neutropenia dehydration dyspnea 61 PANVAC VF 61 IAP inhibitors 61 Generx TM 61 Chronic Hepatitis C 61 malignant ascites 61 pediatric Crohn disease 61 REMINYL ® 61 forodesine hydrochloride 61 valent pneumococcal conjugate vaccine 61 ovarian breast 61 bacterial vaginosis BV 61 lopinavir ritonavir Kaletra 61 Aztreonam 61 Pimavanserin 61 cancer vaccine Norelin 61 Thalomid ® 61 Tocilizumab 61 Boceprevir 61 intravenous iv 61 humanized interleukin 6 61 Investigational Treatment 61 Cushing Syndrome 61 Hypoactive Sexual Desire Disorder 61 zanolimumab 61 reduce serum phosphate 61 5 HT3 antagonist 61 Darinaparsin 61 metastatic RCC 61 CIMZIA TM 61 Azixa 61 Ocrelizumab 61 PSMA ADC 61 myeloproliferative neoplasms 61 HyperAcute 61 Acute Myeloid Leukemia AML 61 liposomal amphotericin B 61 S. aureus bloodstream infections 61 polycythemia vera essential thrombocythemia 61 Onychomycosis 61 valtorcitabine 61 Phase IIIb clinical 61 Helicobacter pylori H. pylori 61 IAP inhibitor 61 refractory CLL 61 KNS # 61 Kuvan R 61 metastatic androgen independent 61 hepatorenal syndrome 61 interleukin IL -# 61 paclitaxel Taxol ® 61 enterococcal 61 Mg Uk 61 Sezary syndrome 61 panitumumab Vectibix 61 Viramidine 61 pancreatic neuroendocrine tumors 61 transplantation HSCT 61 recurrent GBM 61 FLT3 61 Hycamtin ® 61 Chronic Lymphocytic Leukemia CLL 61 protease inhibitor telaprevir 61 Radezolid 61 Phase #b/#a trial 61 mycophenolate mofetil MMF 61 Lenocta TM 61 EOquin 61 Racivir 61 galiximab 61 receiving immunosuppressive therapy 61 Therapeutic Vaccine 61 squamous cell lung cancer